These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10728986)

  • 1. The control of beta-catenin and TCF during embryonic development and cancer.
    Waltzer L; Bienz M
    Cancer Metastasis Rev; 1999; 18(2):231-46. PubMed ID: 10728986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
    Brantjes H; Barker N; van Es J; Clevers H
    Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
    EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCF transcription factors: molecular switches in carcinogenesis.
    Roose J; Clevers H
    Biochim Biophys Acta; 1999 Oct; 1424(2-3):M23-37. PubMed ID: 10528152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of vegetal cortical dorsal factors in the Xenopus egg with the Wnt/beta-catenin signaling pathway.
    Marikawa Y; Elinson RP
    Mech Dev; 1999 Dec; 89(1-2):93-102. PubMed ID: 10559484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function.
    Townsley FM; Cliffe A; Bienz M
    Nat Cell Biol; 2004 Jul; 6(7):626-33. PubMed ID: 15208637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
    Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
    Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans.
    Korswagen HC; Coudreuse DY; Betist MC; van de Water S; Zivkovic D; Clevers HC
    Genes Dev; 2002 May; 16(10):1291-302. PubMed ID: 12023307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.
    Orme MH; Giannini AL; Vivanco MD; Kypta RM
    Mol Cell Neurosci; 2003 Nov; 24(3):673-86. PubMed ID: 14664817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
    Liu C; Li Y; Semenov M; Han C; Baeg GH; Tan Y; Zhang Z; Lin X; He X
    Cell; 2002 Mar; 108(6):837-47. PubMed ID: 11955436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling controls the phosphorylation status of beta-catenin.
    van Noort M; Meeldijk J; van der Zee R; Destree O; Clevers H
    J Biol Chem; 2002 May; 277(20):17901-5. PubMed ID: 11834740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
    Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
    Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.